Your browser doesn't support javascript.
loading
Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation.
Rodina, Anna; Xu, Chao; Digwal, Chander S; Joshi, Suhasini; Patel, Yogita; Santhaseela, Anand R; Bay, Sadik; Merugu, Swathi; Alam, Aftab; Yan, Pengrong; Yang, Chenghua; Roychowdhury, Tanaya; Panchal, Palak; Shrestha, Liza; Kang, Yanlong; Sharma, Sahil; Almodovar, Justina; Corben, Adriana; Alpaugh, Mary L; Modi, Shanu; Guzman, Monica L; Fei, Teng; Taldone, Tony; Ginsberg, Stephen D; Erdjument-Bromage, Hediye; Neubert, Thomas A; Manova-Todorova, Katia; Tsou, Meng-Fu Bryan; Young, Jason C; Wang, Tai; Chiosis, Gabriela.
Afiliação
  • Rodina A; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Xu C; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Digwal CS; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Joshi S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Patel Y; Department of Biochemistry, Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, H3G 0B1, Canada.
  • Santhaseela AR; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Bay S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Merugu S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Alam A; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Yan P; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Yang C; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Roychowdhury T; Changhai Hospital, Second Military Medical University, Shanghai, China.
  • Panchal P; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Shrestha L; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Kang Y; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Sharma S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Almodovar J; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Corben A; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Alpaugh ML; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Modi S; Maimonides Medical Center, Brooklyn, NY, USA.
  • Guzman ML; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Fei T; Rowan University, Glassboro, NJ, USA.
  • Taldone T; Department of Medicine, Division of Solid Tumors, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Ginsberg SD; Department of Medicine, Division of Hematology Oncology, Weill Cornell Medicine, New York, NY, 10065, USA.
  • Erdjument-Bromage H; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Neubert TA; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Manova-Todorova K; Departments of Psychiatry, Neuroscience & Physiology & the NYU Neuroscience Institute, NYU Grossman School of Medicine, New York, NY, 10016, USA.
  • Tsou MB; Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY, 10962, USA.
  • Young JC; Department of Neuroscience and Physiology and Neuroscience Institute, NYU Grossman School of Medicine, New York, NY, 10016, USA.
  • Wang T; Department of Neuroscience and Physiology and Neuroscience Institute, NYU Grossman School of Medicine, New York, NY, 10016, USA.
  • Chiosis G; Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Nat Commun ; 14(1): 3742, 2023 06 23.
Article em En | MEDLINE | ID: mdl-37353488
ABSTRACT
Systems-level assessments of protein-protein interaction (PPI) network dysfunctions are currently out-of-reach because approaches enabling proteome-wide identification, analysis, and modulation of context-specific PPI changes in native (unengineered) cells and tissues are lacking. Herein, we take advantage of chemical binders of maladaptive scaffolding structures termed epichaperomes and develop an epichaperome-based 'omics platform, epichaperomics, to identify PPI alterations in disease. We provide multiple lines of evidence, at both biochemical and functional levels, demonstrating the importance of these probes to identify and study PPI network dysfunctions and provide mechanistically and therapeutically relevant proteome-wide insights. As proof-of-principle, we derive systems-level insight into PPI dysfunctions of cancer cells which enabled the discovery of a context-dependent mechanism by which cancer cells enhance the fitness of mitotic protein networks. Importantly, our systems levels analyses support the use of epichaperome chemical binders as therapeutic strategies aimed at normalizing PPI networks.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mapas de Interação de Proteínas / Neoplasias Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mapas de Interação de Proteínas / Neoplasias Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
...